Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
companies in this sector in the United States:
sales of $36.48 billion
of which 59%
Merck & Co. , Inc.
of which 88%
was Merck Pharmaceutical), and
of which 44%
was Operating Segment-Global Established Pha).
During the year ended December of 2015, sales at
Sanofi S.A. were $38.45 billion.
decrease of 14.6%
versus 2014, when the company's sales were $45.04 billion.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Sanofi S.A. had sales
of $40.11 billion.
Contributing to the drop in overall sales was the 10.2% decline
in Pharmaceuticals, from $36.60 billion to $32.87 billion.
There were also decreases in sales in
Vaccines (down 0.3% to $5.23 billion)
However, these declines were partially offset by the increase in sales of
Animal Health (up 1.2% to $2.77 billion)